IYXI Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume4.42K
Average Volume (3M)615.69K
Market Cap
$53.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.46
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,107,000
10 Day Avg. Volume615,689
30 Day Avg. Volume615,689
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IYXI FAQ
What was Inyx Inc’s price range in the past 12 months?
Inyx Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Inyx Inc’s market cap?
Inyx Inc’s market cap is $53.00.
When is Inyx Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Inyx Inc’s earnings last quarter?
Currently, no data Available
Is Inyx Inc overvalued?
According to Wall Street analysts Inyx Inc’s price is currently Overvalued.
Does Inyx Inc pay dividends?
Inyx Inc does not currently pay dividends.
What is Inyx Inc’s EPS estimate?
Inyx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inyx Inc have?
Inyx Inc has 53,107,000 shares outstanding.
What happened to Inyx Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Inyx Inc?
Currently, no hedge funds are holding shares in IYXI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Inyx Inc
Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications. The company's proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps. It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market. The company was incorporated in 2000 and is based in New York, New York.